SCHEMBL14667394

SCHEMBL14667394

COCCCSCC(=O)Nc1ccc(C)c(C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ CASP1 P29466 1/20 0.63
▸ CASP7 P55210 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ ALDH1A1 P00352 6/20 0.58
▸ MAPT P10636 3/20 0.58
▸ GAA P10253 1/20 0.58
▸ POLB P06746 2/20 0.55
▸ ATM Q13315 1/20 0.51
▸ HDAC3 O15379 1/20 0.50
▸ HDAC4 P56524 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC7 Q8WUI4 1/20 0.50
▸ HDAC2 Q92769 1/20 0.50
▸ HDAC10 Q969S8 1/20 0.50
▸ HDAC11 Q96DB2 1/20 0.50
▸ HDAC8 Q9BY41 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ HDAC9 Q9UKV0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15942860 0.89 ALOX15 (0.52) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667401 0.89 ALOX15 (0.52) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667439 0.86 USP2 (0.46) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667409 0.85 MAPT (0.55) HSD17B10ALDH1A1MAPTGAAPOLB
SCHEMBL14667432 0.83 RECQL (0.55) GAAPOLBHDAC3HDAC4HDAC1
SCHEMBL15942870 0.81 MAPT (0.48) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667397 0.80 ALDH1A1 (0.44) ALDH1A1MAPTHDAC3HDAC1HDAC2
SCHEMBL14667390 0.80 DDX3X (0.50) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667402 0.77 GSTO1 (0.44) USP2ALOX15CASP1CASP7HSD17B10
SCHEMBL14667385 0.76 POLB (0.38) USP2ALOX15CASP1CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802448-B2 Mixed mode ligands PALL CORPORATION (US) 2014-08-12 — — US disclosed
US-20130030154-A1 MIXED MODE LIGANDS PALL CORPORATION (US) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030154-A1 MIXED MODE LIGANDS NCL, NECTIN4, NCLN USP2 2925/4885ALOX15 4665/4885CASP1 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback